Prodrug strategies to enhance the intestinal absorption of peptides

Drug Discovery Today

Volumn 2, Issue 4, 1997, Pages 148-155

  Gangwar, Sanjeev ^b   Pauletti, Giovanni M ^a   Wang, Binghe ^c   Siahaan, Teruna J ^a   Stella, Valentino J ^a   Borchardt, Ronald T ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b Prolinx Inc   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; DESMOPRESSIN; DRUG CARRIER; PEPTIDE; PRODRUG; RO 483657; UNCLASSIFIED DRUG;

BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; HUMAN; INTESTINE ABSORPTION; NONHUMAN; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

EID: 0031126947     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(97)01011-8     Document Type: Review

References (84)

1. 1 Humphrey, M.J. and Ringrose, P.S. (1986) Drug Metab. Rev. 17, 283-310
2. 2 Lee, V.H.L. and Yamamoto, A. (1990) Adv. Drug Delivery Rev. 4, 171-207
3. 3 Modi, N.B. (1994) J. Control. Release 29, 269-281
4. 4 Zhou, X.H. (1994) J. Control. Release 29, 239-252
5. 5 Amidon, G.L. and Lee, H.J. (1994) Annu. Rev. Pharmacol. Toxicol. 34, 321-341
6. 6 Pauletti, G.M. et al. (1996) J. Control. Release 41, 3-17
7. 7 Meizer, D.K.F. and Ziegler, K. (1993) in Biological Barriers to Protein Delivery (K.L. Audus and T. Raub, eds), pp. 339-408, Plenum Press
8. 8 Marks, D.L., Gores, G.J. and LaRusso, N.F. (1995) in Peptide-Based Drug Design (M.D. Taylor and G.L. Amidon, eds), pp. 221-248, American Chemical Society
9. 9 Ruwart, M.J. (1995) in Peptide-Based Drug Design (M.D. Taylor and G.L. Amidon, eds), pp. 249-262, American Chemical Society
10. 10 Alpers, O.H. (1987) in Physiology of the Gastrointestinal Tract (L.R. Johnson, ed.), pp. 1469-1487, Raven Press
11. 11 Adibi, S.A. (1971) J. Clin. Invest. 50, 2266-2275
12. 12 Lee, V.H.L. (1988) Crit. Rev. Ther. Drug Carrier Syst. 5, 69-97
13. 13 Lee, V.H.L et al. (1991) in Peptide and Protein Drug Delivery (Lee, V.H.L., ed.), pp. 691-738, Marcel Dekker
14. 14 Drewe, J. et al. (1993) Br. J. Pharmacol. 108, 298-303
15. 15 Jaehde, U. et al. (1994) Pharm. Res. 11, 442-448
16. 16 Thwaites, D.T., Hirst, B.H. and Simmons, N.L. (1993) Pharm. Res. 10, 674-681
17. 17 Lundin, S. and Artursson, P. (1990) Int. J. Pharm. 64, 181-186
18. 18 Cereijido, M. et al. (1993) in Biological Barriers to Protein Delivery (Audus, K.L. and Raub, T., eds), pp. 3-21, Plenum Press
19. 19 Cereijido, M., Meza, I. and Martínez-Palomo, A. (1981) Am. J. Physiol. 240, C96-C102
20. 20 Madara, J.L. and Dharmsathaphorn, K. (1985) J. Cell Biol. 101, 2124-2133
21. 21 Pauletti, G.M., Okumu, F.W. and Borchardt, R.T. (1997) Pharm. Res. 14, 164-168
22. 22 Conradi, R.A., Burton, P.S. and Borchardt, R.T. (1996) in Lipophilicity in Drug Action and Toxicology (V. Pliska, B. Testa and H. Van de Waterbeemd, eds), pp. 233-250, VCH
23. 23 Pauletti, G.M. et al. (1996) Pharm. Res. 13, 1615-1623
24. 24 Okumu, F.W. et al. (1997) Pharm. Res. 14, 169-175
25. 25 Gangwar, S. et al. (1996) Pharm. Res. 13, 1657-1662
26. 26 Okumu, F.W. et al. (1995) Pharm. Res. 12, S302
27. 27 Hansch, C. and Fujita, T. (1964) J. Am. Chem. Soc. 86, 1616-1626
28. 28 Smith, R.N., Hansch, C. and Ames, M.M. (1975) J. Pharm. Sci. 64, 599-606
29. 29 Leo, A., Hansch, C. and Elkins, D. (1971) Chem. Rev. 71, 525-616
30. 30 Austel, V. and Kutter, E. (1983) in Quantitative Structure-Activity Relationships of Drugs (Topliss, J.G., ed.), pp. 437-496, Academic Press
31. 31 Conradi, R.A. et al. (1992) Pharm. Res. 9, 435-439
32. 32 Kim, D.C., Burton, P.S. and Borchardt, R.T. (1993) Pharm. Res. 10, 1710-1714
33. 33 Hidalgo, I.J. et al. (1993) Int. J. Pharm. 98, 83-92
34. 34 Bai, J.P.F. (1995) Pharm. Res. 12, 1101-1104
35. 35 Hu, M. and Amidon, G.L. (1988) J. Pharm. Sci. 77, 1007-1011
36. 36 Walter, E. et al. (1995) Pharm. Res. 12, 360-365
37. 37 Walter, E., Kissel, T. and Amidon, G.L. (1996) Adv. Drug Delivery Rev. 20, 33-58
38. 38 Hidalgo, I.J. et al. (1993) Pharm. Res. 10, S181
39. 39 Hidalgo, I.J. et al. (1995) Pharm. Res. 12, 317-319
40. 40 Wootton, R. and Hazelwood, R. (1989) Biochem. Soc. Trans. 17, 691-692
41. 41 Tamura, K. et al. (1996) Pharm. Res. 13, 1752-1754
42. 42 Tamura, K. et al. (1996) Pharm. Res. 13, 1223-1228
43. 43 Tamura, K. et al. (1996) Pharm. Res. 13, 1663-1667
44. 44 Siminoski, K. et al. (1986) J. Cell Biol. 103, 1979-1990
45. 45 Krähenbühl, J.P. and Campiche, M.A. (1969) J. Cell Biol. 42, 345-365
46. 46 Strous, G.J. and Dekker, J. (1992) Crit. Rev. Biochem. Mol. Biol. 27, 57-92
47. 47 Forstner, J.F. and Forstner, G.G. (1994) in Physiology of the Gastrointestinal Tract (Johnson, L.R., ed.), pp. 1255-1283, Raven Press
48. 48 Crampton, R.F., Lis, M.T. and Matthews, D.M. (1973) Clin. Sci. 44, 583-594
49. 49 Kania, R.J., Santiago, N.A. and Gray, G.M. (1972) Gastroenterology 62, 768A
50. 50 Matthews, D.M. and Payne, J.W. (1980) Curr. Top. Membr. Transp. 14, 331-425
51. 51 Kim, Y.S., Birtwhistle, W. and Kim, Y.W. (1972) J. Clin. Invest. 51, 1419-1430
52. 52 Barrett, A.J. and McDonald, J.K. (1980) Mammalian Proteases: a Glossary and Bibliography, Vol. 1, Endopeptidases, Academic Press
53. 53 McDonald, J.K. and Barrett, A.J. (1986) Mammalian Proteases: a Glossary and Bibliography, Vol. 2, Exopeptidases, Academic Press
54. 54 Bond, J.S. and Beynon, R.J. (1987) Mol. Aspects Med. 9, 173-287
55. 55 Bai, J.P.F. (1994) J. Pharm. Pharmacol. 46, 928-930
56. 56 Leitch, G.J. (1971) Arch. Int. Physiol. Biochem. 79, 279-286
57. 57 Lindberg, T. (1966) Acta Physiol. Scand. 66, 437-443
58. 58 Sterchi, E.E. (1981) Pediatr. Res. 15, 884-885
59. 59 Bai, J.P.F. (1994) Int. J. Pharm. 107, 133-140
60. 60 Vaeth, G.F. and Henning, S.J. (1982) J. Pediatr. Gastroenterol. Nutr. 1, 111-117
61. 61 Nicholson, J.A., McCarthy, D.M. and Kim, Y.S. (1974) J. Clin. Invest. 54, 890-898
62. 62 Suzuki, Y. et al. (1995) Nutr. Res. 15, 571-579
63. 63 Miura, S. et al. (1983) Gastroenterology 85, 1340-1349
64. 64 Peters, W.H.M. et al. (1992) Gastroenterology 103, 448-455
65. 65 Gottesman, M.M. and Pastan, I. (1993) Annu. Rev. Biochem. 62, 385-427
66. 66 Burton, P.S., Conradi, R.A. and Ho, N.F.H. (1993) Biochem. Biophys. Res. Commun. 190, 760-766
67. 67 Burton, P.S. et al. Adv. Drug Delivery Rev. (in press)
68. 68 Amsberry, K.L. and Borchardt, R.T. (1990) J. Org. Chem. 55, 5867-5877
69. 69 Amsberry, K.L., Gerstenberger, A.E. and Borchardt, R.T. (1991) Pharm. Res. 8, 455-461
70. 70 Bundgaard, H. (1985) in Design of Prodrugs (Bundgaard, H., ed.), pp. 1-92, Elsevier
71. 71 Bundgaard, H. and Rasmussen, G.J. (1991) Pharm. Res. 8, 1238-1242
72. 72 Bundgaard, H. (1992) Adv. Drug Delivery Rev. 8, 1-38
73. 73 Stella, V.J., Charman, W.N.A. and Naringrekar, V.H. (1985) Drugs 29, 455-473
74. 74 Oliyai, R. and Stella, V.J. (1993) Annu. Rev. Pharmacol. Toxicol. 32, 521-544
75. 75 Oliyai, R. (1996) Adv. Drug Delivery Rev. 19, 275-286
76. 76 Weller, T. et al. (1996) J. Med. Chem. 39, 3139-3147
77. 77 Kim, J.S. et al. (1994) J. Pharm. Sci. 83, 1350-1356
78. 78 Kahns, A.H., Buur, A. and Bundgaard, H. (1993) Pharm. Res. 10, 68-74
79. 79 Bundgaard, H. and Møss, J. (1990) Pharm. Res. 7, 885
80. 80 Gangwar, S. et al. (1997) J. Org. Chem. 62, 1356-1362
81. 81 Pauletti, G.M. et al. (1997) Pharm. Res. 14, 11-17
82. 82 Wang, B. et al. (1997) J. Org. Chem. 62, 1363-1367
83. 83 Alexander, J. et al. (1991) J. Med. Chem. 34, 78-81
84. 84 Gogate, U.S., Repta, A.J. and Alexander, J. (1987) Int. J. Pharm. 40, 235-248